140 related articles for article (PubMed ID: 8440923)
1. Risk of melanoma and other cancers in melanoma-prone families.
Tucker MA; Fraser MC; Goldstein AM; Elder DE; Guerry D; Organic SM
J Invest Dermatol; 1993 Mar; 100(3):350S-355S. PubMed ID: 8440923
[TBL] [Abstract][Full Text] [Related]
2. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi.
Greene MH; Clark WH; Tucker MA; Kraemer KH; Elder DE; Fraser MC
Ann Intern Med; 1985 Apr; 102(4):458-65. PubMed ID: 3977193
[TBL] [Abstract][Full Text] [Related]
3. A cohort study of melanoma in patients with dysplastic nevi.
Halpern AC; Guerry D; Elder DE; Trock B; Synnestvedt M
J Invest Dermatol; 1993 Mar; 100(3):346S-349S. PubMed ID: 8440922
[TBL] [Abstract][Full Text] [Related]
4. Multiple primary melanomas.
Stam-Posthuma JJ; van Duinen C; Scheffer E; Vink J; Bergman W
J Am Acad Dermatol; 2001 Jan; 44(1):22-7. PubMed ID: 11148472
[TBL] [Abstract][Full Text] [Related]
5. Dysplastic nevi and other risk markers for melanoma.
Seykora J; Elder D
Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
Schneider JS; Moore DH; Sagebiel RW
Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
[TBL] [Abstract][Full Text] [Related]
7. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
Tucker MA; Fraser MC; Goldstein AM; Struewing JP; King MA; Crawford JT; Chiazze EA; Zametkin DP; Fontaine LS; Clark WH
Cancer; 2002 Jun; 94(12):3192-209. PubMed ID: 12115352
[TBL] [Abstract][Full Text] [Related]
8. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma.
Carey WP; Thompson CJ; Synnestvedt M; Guerry D; Halpern A; Schultz D; Elder DE
Cancer; 1994 Dec; 74(12):3118-25. PubMed ID: 7982177
[TBL] [Abstract][Full Text] [Related]
9. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families.
Novakovic B; Clark WH; Fears TR; Fraser MC; Tucker MA
J Am Acad Dermatol; 1995 Oct; 33(4):631-6. PubMed ID: 7673498
[TBL] [Abstract][Full Text] [Related]
10. On the interplay of telomeres, nevi and the risk of melanoma.
Bodelon C; Pfeiffer RM; Bollati V; Debbache J; Calista D; Ghiorzo P; Fargnoli MC; Bianchi-Scarra G; Peris K; Hoxha M; Hutchinson A; Burdette L; Burke L; Fang S; Tucker MA; Goldstein AM; Lee JE; Wei Q; Savage SA; Yang XR; Amos C; Landi MT
PLoS One; 2012; 7(12):e52466. PubMed ID: 23300679
[TBL] [Abstract][Full Text] [Related]
11. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Fraser MC; Clark WH; Tucker MA
J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
[TBL] [Abstract][Full Text] [Related]
12. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
[TBL] [Abstract][Full Text] [Related]
13. Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades.
Tucker MA; Elder DE; Curry M; Fraser MC; Pichler V; Zametkin D; Yang XR; Goldstein AM
J Invest Dermatol; 2018 Jul; 138(7):1620-1626. PubMed ID: 29408205
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
[TBL] [Abstract][Full Text] [Related]
15. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
[TBL] [Abstract][Full Text] [Related]
16. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
Goldstein AM; Martinez M; Tucker MA; Demenais F
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
[TBL] [Abstract][Full Text] [Related]
17. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives.
Albert LS; Rhodes AR; Sober AJ
J Am Acad Dermatol; 1990 Jan; 22(1):69-75. PubMed ID: 2298967
[TBL] [Abstract][Full Text] [Related]
18. Natural history of dysplastic nevi.
Halpern AC; Guerry D; Elder DE; Trock B; Synnestvedt M; Humphreys T
J Am Acad Dermatol; 1993 Jul; 29(1):51-7. PubMed ID: 8315078
[TBL] [Abstract][Full Text] [Related]
19. Dysplastic nevi are a risk factor for uveal melanoma.
Hammer H; Oláh J; Tóth-Molnár E
Eur J Ophthalmol; 1996; 6(4):472-4. PubMed ID: 8997595
[TBL] [Abstract][Full Text] [Related]
20. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma.
Roush GC; Nordlund JJ; Forget B; Gruber SB; Kirkwood JM
Prev Med; 1988 May; 17(3):273-9. PubMed ID: 3405984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
